Mercer Global Advisors
ELDN icon

Mercer Global Advisors’s Eledon Pharmaceuticals ELDN Stock Holding History

Mercer Global Advisors’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$132K Buy
33,499
+18,357
+121% +$66.8K ﹤0.01% 3365
2026
Q1 		$46.6K Sell
15,142
-2,542
-14% -$5.99K ﹤0.01% 3127
2025
Q4 		$26.7K Buy
17,684
+881
+5% +$2.09K ﹤0.01% 2815
2025
Q3 		$43.5K Buy
16,803
+77
+0.5% +$225 ﹤0.01% 2595
2025
Q2 		$45.3K Hold
16,726
– – ﹤0.01% 2207
2025
Q1 		$56.7K Hold
16,726
– – ﹤0.01% 2096
2024
Q4 		$68.9K Hold
16,726
– – ﹤0.01% 2067
2024
Q3 		$40.8K Hold
16,726
– – ﹤0.01% 1925
2024
Q2 		$44.2K Hold
16,726
– – ﹤0.01% 1918
2024
Q1 		$34K Hold
16,726
– – ﹤0.01% 1908
2023
Q4 		$30K Hold
16,726
– – ﹤0.01% 1978
2023
Q3 		$23K Hold
16,726
– – ﹤0.01% 1923
2023
Q2 		$23K Hold
16,726
– – ﹤0.01% 1890
2023
Q1 		$39K Hold
16,726
– – ﹤0.01% 1878
2022
Q4 		$38K Hold
16,726
– – ﹤0.01% 1879
2022
Q3 		$46K Hold
16,726
– – ﹤0.01% 1776
2022
Q2 		$41K Hold
16,726
– – ﹤0.01% 1776
2022
Q1 		$66K Hold
16,726
– – ﹤0.01% 1820
2021
Q4 		$74K Hold
16,726
– – ﹤0.01% 1737
2021
Q3 		$103K Buy
+16,726
New +$117K ﹤0.01% 1684

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Mercer Global Advisors's ELDN Position: Q2 2026 in Review

Mercer Global Advisors increased its Eledon Pharmaceuticals (ELDN) stake by 121% in Q2 2026, buying an estimated $66.8K and bringing the position to 33,499 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #3365.

Mercer Global Advisors first reported a position in ELDN in Q3 2021 and has held it in 20 quarters since. 160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Mercer Global Advisors held 33,499 shares of Eledon Pharmaceuticals worth $132K as of Q2 2026.
  • Mercer Global Advisors bought 18,357 Eledon Pharmaceuticals shares in Q2 2026, an estimated $66.8K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3365 holding.
  • Mercer Global Advisors first reported a position in Eledon Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • 160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.